Unknown OBSERVATIONAL NCT02581735

Effectiveness of the uPatient Platform in Prophylactic Treatment in Hemophilia (uPatient)

Effectiveness of the uPatient Platform in the Fulfillment of the Prophylactic Treatment in Patients With Hemophilia

Sponsor: Medtep Inc.

Updated 7 times since 2017 Last updated: Jun 29, 2016 Started: Oct 31, 2015 Primary completion: Nov 30, 2016 Completion: Nov 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Haemophilia, this trial is ongoing. The trial is conducted by Medtep Inc. and has accumulated 7 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status
Jul 2018 — Jan 2021 [monthly]

Unknown Status

Status: Active Not Recruiting → Unknown Status
Jun 2018 — Jul 2018 [monthly]

Active Not Recruiting

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Active Not Recruiting

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Active Not Recruiting NA

First recorded

Oct 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medtep Inc.
Real Fundación Victoria Eugenia
Universidad de Murcia

Data source: Real Fundación Victoria Eugenia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.